Novo Nordisk continues to deliver double-digit revenue and profit growth, driven by both its diabetes and obesity drug ...

Pancreatitis, vision loss ... the risks of drugs such as Ozempic can sound scary. But what does the evidence show?

The pioneering Danish drugmaker was once the most valuable company in Europe, but analysts say a number of missteps reversed ...

Because chronic inflammation is key to aging, Ozempic’s anti-inflammatory effects (among others) make it a powerful ...

Otto’s, a French restaurant in London known for rich feasts of canard à la presse, lobster soufflé and crêpes suzette, introduced a “menu for one, small appetite” in May. The tasting menu, which costs ...

Some studies have linked the popular weight-loss drugs with a potentially higher risk of eye problems and vision loss. Should ...

Among US adolescents, current medical use of prescription stimulants for ADHD increased between 2005 and 2023, while nonmedical use decreased.

Kids and teens who spend more time on screens and get less sleep may have higher risks for future heart and metabolic ...

GLP-1 drugs like Ozempic are transforming weight loss, but a new UVA study warns they're not improving a critical measure of ...

Baron Capital’s Q2 report highlights biotech, surgical tech, and GLP-1 winners. Discover which health care stocks surged and ...

OPENING my 10th can of cola of the day and gorging on a Chinese takeaway, I felt utterly miserable. Weighing 29st and a size ...

Despite concerns about increased stimulant prescribing, nonmedical use of ADHD drugs among adolescents has declined in the last 20 years, a University of Michigan study shows.